Skip to main content

Month: April 2024

Stronghold Announces Preliminary First Quarter 2024 Results

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) today reported preliminary unaudited financial results for the first quarter ended March 31, 2024: First Quarter 2024 Financial Performance Stronghold generated an estimated $27.5 million of revenue, an estimated $5.8 million of GAAP Net Income, and an estimated $8.7 million of adjusted EBITDA1 during the first quarter of 2024. Revenue comprised an estimated $26.7 million from cryptocurrency mining, an estimated $0.7 million from the sale of energy, and an estimated $0.1 million of other revenue during the quarter. The period featured two extremes: improving Bitcoin mining economics from January through March and depressed PJM power prices to end the winter in January and February. In addition to the improved...

Continue reading

Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene

Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion gene Approval based on results from a randomized Phase 2/3 trial FOSTER CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that its partner in China, Avistone Biotechnology Co. Ltd. (Avistone), received approval from the National Medical Products Administration (NMPA) of China for vebreltinib (APL-101) for the treatment of adult patients with isocitrate dehydrogenase (IDH) mutant astrocytoma (WHO Grade 4) or glioblastoma with a history of low-grade...

Continue reading

ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures

25 April 2024, 14:30 CET ArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus figures. The consensus figures are based on analysts’ estimates recorded on an external web-based tool provided and managed by an independent company, Visible Alpha. To arrive at the consensus figures below, Visible Alpha has aggregated the expectations of sell-side analysts who, to the best of our knowledge, cover ArcelorMittal on a continuous basis. Sell-side analysts follow ArcelorMittal on their own initiative and ArcelorMittal is not responsible for their views. ArcelorMittal is neither involved in the collection of the information nor in the compilation of the estimates. 1Q’24 consensus estimates*:                                           1Q’24                        EBITDA ($m)                        $1,814                         Net...

Continue reading

ACNB Corporation Reports 2024 First Quarter Financial Results

GETTYSBURG, Pa., April 25, 2024 (GLOBE NEWSWIRE) — ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $6.8 million, or $0.80 per diluted earnings per share, for the three months ended March 31, 2024 compared to net income of $9.0 million, or $1.06 per diluted earnings per share, for the three months ended March 31, 2023. Compared to the three months ended December 31, 2023, net income and diluted earnings per share for the three months ended March 31, 2024 increased $2.7 million and $0.32, respectively. The financial results for the three month period ended December 31, 2023 were impacted by the repositioning of the investment securities portfolio as announced on Form 8-K on December 15, 2023. 2024 First Quarter HighlightsReturn...

Continue reading

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release first quarter 2024 financial results on Monday, May 6, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time. To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access...

Continue reading

Vegard Søraunet declines re-election to SkiStar’s board of directors at the annual general meeting in December

The nomination committee for the annual general meeting in December 2024 appointed The board member of SkiStar AB (publ) Vegard Søraunet has informed SkiStar’s nomination committee that he declines re-election at SkiStar’s annual general meeting, which is intended to be held in December 2024. This is due to a change of ownership in Nordic Ski & Mountains AB, which is a major shareholder in SkiStar. Søraunet, who represents Aeternum Capital, which continues to be a minority owner of Nordic Ski & Mountains AB, has been a member of SkiStar’s board since the annual general meeting in 2021. SkiStar’s nomination committee will work to propose a replacement in the regular nomination process before SkiStar’s annual general meeting in December. In accordance with the nomination committee’s instructions,...

Continue reading

SUPPLEMENT – Inside information: Meriaura Group’s board has conditionally decided to sell Meriaura’s minority ownership to Meriaura Invest to rearrange the group’s financing

Meriaura Group Plc Company announcement, Inside information                                                    25 April 2024 at 14.00 (CEST) SUPPLEMENT – Inside information: Meriaura Group’s board has conditionally decided to sell Meriaura’s minority ownership to Meriaura Invest to rearrange the group’s financing With this release, Meriaura Group Plc supplements the company announcement issued earlier today on April 25, 2024, at 8:30 (CEST). The supplement includes the legal forms of the companies mentioned in the first paragraph of the announcement, as well as the position within the group and the current estimate of the amount of minority ownership of Meriaura Ltd potentially to be sold in the arrangement under discussion. To rearrange the overall financing situation of the group, the Board of Directors of Meriaura...

Continue reading

Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement

MUNICH, Germany, April 25, 2024 (GLOBE NEWSWIRE) — Sono Group N.V. (the “Company”), a solar technology company, is pleased to announce a significant milestone in its corporate recovery. Following the successful conclusion of insolvency proceedings involving its subsidiary, Sono Motors GmbH, and the withdrawal of its own application for preliminary self-administration proceedings (reported in the Company’s Form 6-Ks filed on January 31, 2024 and February 29, 2024, respectively), the Company has received from the Financial Industry Regulatory Authority (FINRA) that the ‘Q’ will be removed from its ticker symbol, previously designated as SEVCQ, effective today. This change marks the end of the bankruptcy indication for Sono Group N.V., and the Company’s ordinary shares will be quoted on the over-the-counter market...

Continue reading

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1×1 Meetings on Thursday, May 2, 2024

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST. Ted Karkus, CEO, will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2024Date: Wednesday, May 1, 2024 Time: 2:30pm Eastern Time (11:30am Pacific Time) Webcast: https://www.webcaster4.com/Webcast/Page/3026/50164 If you would like to book 1×1 investor meetings with ProPhase Labs, and to attend the Planet MicroCap Showcase: VEGAS 2024, please make sure you are registered here: https://planetmicrocapshowcase.com/signup 1×1 meetings...

Continue reading

American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada

The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need.American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and NevadaFrom left to right: Shelly Glenn, AON’s chief growth & relationship officer; Raja S. Mehdi, MD, medical oncologist at Hope Cancer Care of Nevada; Brian P. Mulherin, MD, medical oncologist at Hematology Oncology of Indiana; and Todd Schonherz, AON’s chief executive officer.FORT MYERS, Fla., April 25, 2024 (GLOBE NEWSWIRE) — American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, today launched its American Oncology Cares Foundation through its partner practices Hematology Oncology of Indiana...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.